{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:26:36Z","timestamp":1762417596387,"version":"build-2065373602"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009128","name":"Research for Patient Benefit Programme","doi-asserted-by":"publisher","award":["NIHR201124"],"award-info":[{"award-number":["NIHR201124"]}],"id":[{"id":"10.13039\/501100009128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Obstructive sleep apnoea is caused by closure of the upper airway during sleep due to excessive muscle relaxation. It is treated with continuous positive airway pressure (CPAP), a machine connected to a mask worn by a patient during sleep, which generates pressure to keep the throat open. CPAP is highly effective, but often not tolerated, sometimes due to the required pressure of the machine. Mandibular advancement devices advance the lower jaw, increasing airway space. Using such a device may open the airway enough to allow CPAP pressure to be reduced, resulting in more patients being able to tolerate using the CPAP machine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods\/design<\/jats:title>\n                    <jats:p>The PAPMAT trial is a multicentre, randomised controlled crossover trial. It will measure CPAP machine adherence for participants with obstructive sleep apnoea, comparing their adherence when using a CPAP machine alone to using a CPAP machine in conjunction with a mandibular advancement device. The sample size will be re-estimated after at least 50% of participants have completed follow-up. This document is the statistical analysis plan, which gives details of the planned analysis, including the sample size re-estimation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>ISRCTN 33966032. Registered 18th February 2022.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-025-09126-9","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:23:33Z","timestamp":1762417413000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Statistical analysis plan for continuous positive airway pressure plus mandibular advancement therapy (PAPMAT): an adaptive randomised crossover trial comparing the benefits and costs of combining two established treatments for obstructive sleep apnoea"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9594-348X","authenticated-orcid":false,"given":"Martin","family":"Law","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Da","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sof\u00eda S.","family":"Villar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Quinnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"9126_CR1","doi-asserted-by":"publisher","unstructured":"Moyer CA, Sonnad SS, Garetz SL, Helman JI, Chervin RD. Quality of life in obstructive sleep apnea: a systematic review of the literature. Sleep Med. 2001;14592263. https:\/\/doi.org\/10.1016\/s1389-9457(01)00072-7.","DOI":"10.1016\/s1389-9457(01)00072-7"},{"key":"9126_CR2","first-page":"ii45","volume":"56","author":"JR Stradling","year":"2001","unstructured":"Stradling JR, Pepperell JC, Davies RJ. Sleep apnoea and hypertension: proof at last? Thorax. 2001;56:ii45-49.","journal-title":"Thorax"},{"key":"9126_CR3","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.atherosclerosis.2013.04.026","volume":"229","author":"JY Dong","year":"2013","unstructured":"Dong JY, Zhang YH, Qin LQ. Obstructive sleep apnea and cardiovascular risk: meta-analysis of prospective cohort studies. Atherosclerosis. 2013;229:489\u2013549.","journal-title":"Atherosclerosis"},{"key":"9126_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta18670","volume":"18","author":"L Sharples","year":"2014","unstructured":"Sharples L, Glover M, Clutterbuck-James A, et al. Clinical effectiveness and cost effectiveness results from the randomised controlled trial of oral mandibular advancement devices for obstructive sleep apnoea-hypopnoea (TOMADO) and long-term economic analysis of oral devices and continuous positive airway pressure. Health Technol Assess. 2014;18:1\u2013296.","journal-title":"Health Technol Assess"},{"key":"9126_CR5","doi-asserted-by":"publisher","unstructured":"Smith I, Lasserson TJ. Pressure modification for improving usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD003531. https:\/\/doi.org\/10.1002\/14651858.CD003531.pub3.","DOI":"10.1002\/14651858.CD003531.pub3"},{"key":"9126_CR6","doi-asserted-by":"publisher","first-page":"10938","DOI":"10.1136\/thoraxjnl-2014-205464","volume":"69","author":"TG Quinnell","year":"2014","unstructured":"Quinnell TG, Bennett M, Jordan J, et al. A crossover randomised controlled trial of oral mandibular advancement devices for obstructive sleep apnoea-hypopnoea. Thorax. 2014;69:10938\u201345.","journal-title":"Thorax"},{"key":"9126_CR7","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1056\/NEJM199304293281704","volume":"328","author":"T Young","year":"1993","unstructured":"Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230\u20135.","journal-title":"N Engl J Med"},{"key":"9126_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.wjorl.2015.08.001","volume":"1","author":"M Knauert","year":"2015","unstructured":"Knauert M, Naik S, Gillespie MB, Kryger M. Clinical consequences and economic costs of untreated obstructive sleep apnea syndrome. World journal of otorhinolaryngology - head and neck surgery. 2015;1:17\u201327. https:\/\/doi.org\/10.1016\/j.wjorl.2015.08.001.","journal-title":"World journal of otorhinolaryngology - head and neck surgery"},{"issue":"2","key":"9126_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1515\/reveh-2018-0068","volume":"34","author":"N Morsy","year":"2019","unstructured":"Morsy N, Farrag N, Zaki N, et al. Obstructive sleep apnea: personal, societal, public health, and legal implications. Rev Environ Health. 2019;34(2):153\u201369.","journal-title":"Rev Environ Health"},{"issue":"2","key":"9126_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1532-5415.2007.01544.x","volume":"56","author":"A Tarasiuk","year":"2008","unstructured":"Tarasiuk A, Greenberg-Dotan S, Simon-Tuval T, Oksenberg A, Reuveni H. The effect of obstructive sleep apnea on morbidity and health care utilization of middle-aged and older adults. J Am Geriatr Soc. 2008;56(2):247\u201354.","journal-title":"J Am Geriatr Soc"},{"issue":"10","key":"9126_CR11","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1093\/sleep\/29.10.1307","volume":"29","author":"K Banno","year":"2006","unstructured":"Banno K, Manfreda J, Walld R, Delaive K, Kryger MH. Healthcare utilization in women with obstructive sleep apnea syndrome 2 years after diagnosis and treatment. Sleep. 2006;29(10):1307\u201311. https:\/\/doi.org\/10.1093\/sleep\/29.10.1307.","journal-title":"Sleep"},{"issue":"10","key":"9126_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187032","volume":"12","author":"H-W Liu","year":"2017","unstructured":"Liu H-W, Chen Y-J, Lai Y-C, Huang C-Y, Huang Y-L, Lin M-T, et al. Combining MAD and CPAP as an effective strategy for treating patients with severe sleep apnea intolerant to high- pressure PAP and unresponsive to MAD. PLoS ONE. 2017;12(10):e0187032.","journal-title":"PLoS ONE"},{"key":"9126_CR13","doi-asserted-by":"crossref","unstructured":"McDaid C, Griffin S, Weatherly H, Dur\u00e9e K, Van der Burgt M, Van Hout S, Akers J, et al. Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis. Health Technol Assess 2009:13(4)1\u2013146.","DOI":"10.3310\/hta13040"},{"key":"9126_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2007.086454","author":"JF Guest","year":"2008","unstructured":"Guest JF, Helter MT, Morga A, Stradling JR. Cost-effectiveness of using continuous positive airway pressure in the treatment of severe obstructive sleep apnoea\/hypopnoea syndrome in the UK. Thorax. 2008. https:\/\/doi.org\/10.1136\/thx.2007.086454.","journal-title":"Thorax"},{"key":"9126_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1136\/thorax.57.1.93","volume":"57","author":"NJ Douglas","year":"2002","unstructured":"Douglas NJ, George CFP. Treating sleep apnoea is cost effective. Thorax. 2002;57:93.","journal-title":"Thorax"},{"issue":"1","key":"9126_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4038\/jnsfsr.v39i1.2929","volume":"39","author":"NM Siyasinghe","year":"2002","unstructured":"Siyasinghe NM, Sooriyarachchi MR. Guidelines for calculating sample size in 2x2 crossover trials: a simulation study. J Natl Sci Found. 2002;39(1):77\u201389. https:\/\/doi.org\/10.4038\/jnsfsr.v39i1.2929.","journal-title":"J Natl Sci Found"},{"key":"9126_CR17","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/pst.185","volume":"4","author":"SA Julious","year":"2005","unstructured":"Julious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat. 2005;4:287\u201391. https:\/\/doi.org\/10.1002\/pst.185.","journal-title":"Pharm Stat"},{"key":"9126_CR18","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1002\/bimj.4710380806","volume":"8","author":"M Kieser","year":"1996","unstructured":"Kieser M, Wassmer G. On the use of the upper confidence limit for the variance from a pilot sample for sample size determination. Biom J. 1996;8:941\u20139.","journal-title":"Biom J"},{"key":"9126_CR19","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jclinepi.2011.07.011","volume":"65","author":"J Sim","year":"2012","unstructured":"Sim J, Lewis M. The size of a pilot study for a clinical trial should be calculated in relation to considerations of precision and efficiency. J Clin Epidemiol. 2012;65:301\u20138.","journal-title":"J Clin Epidemiol"},{"key":"9126_CR20","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/1745-6215-15-264","volume":"15","author":"MD Teare","year":"2014","unstructured":"Teare MD, Dimairo M, Shephard N, et al. Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study. Trials. 2014;15:264\u2013264.","journal-title":"Trials"},{"issue":"3","key":"9126_CR21","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1177\/0962280215588241","volume":"25","author":"AL Whitehead","year":"2016","unstructured":"Whitehead AL, Julious SA, Cooper CL, Campbell MJ. Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable. Stat Med Res. 2016;25(3):1057\u201373. https:\/\/doi.org\/10.1177\/0962280215588241.","journal-title":"Stat Med Res"},{"issue":"1","key":"9126_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/mpr.329","volume":"20","author":"MJ Azur","year":"2011","unstructured":"Azur MJ, Stuart EA, Frangakis C, Leaf PJ. Multiple imputation by chained equations: what is it and how does it work? Int J Methods Psychiatr Res. 2011;20(1):40\u20139.","journal-title":"Int J Methods Psychiatr Res"},{"key":"9126_CR23","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","volume":"30","author":"IR White","year":"2010","unstructured":"White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2010;30:377\u201399.","journal-title":"Stat Med"},{"key":"9126_CR24","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1080\/01621459.1988.10478722","volume":"83","author":"RJA Little","year":"1988","unstructured":"Little RJA. A test of missing completely at random for multivariate data with missing values. J Am Stat Assoc. 1988;83:1198\u2013202.","journal-title":"J Am Stat Assoc"},{"issue":"5","key":"9126_CR25","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.jval.2012.02.008","volume":"15","author":"B van Hout","year":"2012","unstructured":"van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15(5):708\u201315. https:\/\/doi.org\/10.1016\/j.jval.2012.02.008.","journal-title":"Value Health"},{"key":"9126_CR26","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0167-6296(01)00130-8","volume":"21","author":"J Brazier","year":"2002","unstructured":"Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21:271\u201392. https:\/\/doi.org\/10.1016\/S0167-6296(01)00130-8.","journal-title":"J Health Econ"},{"key":"9126_CR27","doi-asserted-by":"crossref","unstructured":"Dimairo M, Pallmann P, Wason J, Todd S, Jaki T, Julious SA et al. The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design. BMJ. 2020;369:m115. PMID: 32554564; PMCID: PMC7298567.","DOI":"10.1136\/bmj.m115"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09126-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-09126-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09126-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:23:38Z","timestamp":1762417418000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-025-09126-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9126"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-09126-9","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"23 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As the protocol, before the start of the study, or implementation of any amendment, [LE1]\u00a0 of the trial protocol, protocol amendments, informed consent forms, and other relevant documents will be obtained from the Research Ethics Committee (REC) and Health Research Authority. All correspondence with the REC and Research for Patient Benefit will be retained in the Trial Master File (sponsor file\/investigator site file). Annual reports will be submitted to the REC in accordance with national requirements. It is the chief investigator\u2019s responsibility to produce the annual reports as required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"As protocol, a model consent form can be provided on request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"472"}}